Gå till Affärer
Riskkapital | Konsument- & detaljhandel

Twin City Knitting has raised funds

Twin City Knitting (TCK) has completed a debt financing with Boathouse Capital.

TCK is the largest domestic manufacturer of branded on-field athletic socks and accessories, serving the highly attractive team sports category via an omni-channel model with substantial digital presence. TCK offers a diverse product portfolio of more than 12,000 SKUs including branded, custom-made, collegiate-licensed and private label socks and related accessories.

Oaklins TM Capital in the US served as the exclusive financial advisor to TCK in connection with its debt financing provided by Boathouse Capital.

Prata med transaktionsteamet

Jerome S. Romano

Managing Director
Boston, USA
Oaklins TM Capital

Philip S. Krieger

Managing Director
Atlanta, USA
Oaklins TM Capital

Joseph Kapur

Associate
Boston, USA
Oaklins TM Capital

Relaterade affärer

OBI Group has acquired the OBI and individual DIG stores from Migros
Konsument- & detaljhandel

OBI Group has acquired the OBI and individual DIG stores from Migros

As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.

Lär dig mer
Den Berk Délice accelerates growth through strategic partnership
Riskkapital | Jordbruk

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Lär dig mer
Xiel Limited has been acquired by MIS Healthcare
Riskkapital | Hälsovård

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Lär dig mer